Insider Transactions Reported by 17 Insiders of NovaBay Pharmaceuticals, Inc.

Symbol
NBY on NYSE
Location
Emeryville, CA

Insiders trading volume in the past year

NovaBay Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Framework Ventures IV L.P. 10%+ Owner $74,228,504 16 Oct 2025
R01 Fund LP 10%+ Owner $74,228,504 16 Oct 2025
Michael John Kazley Chief Executive Officer, Director, 10%+ Owner $74,228,504 16 Oct 2025
David E. Lazar 10%+ Owner $36,028,320 21 Oct 2025
POPLAR POINT CAPITAL PARTNERS LP 10%+ Owner $474,440 +$143,597 +43% 02 Apr 2025
Andrew D. Jones Cfo $230,704 15 Feb 2023
Justin Hall CEO, GC and Director, Director $150,541 14 Sep 2022
Yongxiang Zheng Director $54,300 28 May 2024
Yenyou Zheng Director $54,300 28 May 2024
Xinzhou Li Director, 10%+ Owner $54,300 21 May 2021
Julie Garlikov Director $54,300 28 May 2024
MIJIA WU Director $54,300 28 May 2024
Paul E. Freiman Director $54,300 28 May 2024
Swan Sit Director $54,300 28 May 2024
Jeffrey Kunin President, DERMAdoctor, LLC 06 Dec 2022
Audrey Kunin Chief Product Officer 06 Dec 2022
Tommy Law Interim CFO 16 Feb 2023

Recent Insider Transactions by Companies or Individuals for NovaBay Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.